Limitha Adimala

Limitha Adimala practices at John Peter Smith Hospital in Fort Worth, Texas, part of Tarrant County, Texas.

Limitha Adimala's NPI, 1144639030, was assigned on August 5, 2014. Limitha Adimala holds Alabama license 37344.

Limitha Adimala's primary practice is John Peter Smith Hospital, at 1500 S Main St, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 921-3431.

Limitha Adimala's primary practice is John Peter Smith Hospital in Fort Worth, Texas, part of Tarrant County, Texas. The medical group on file is Sound Physicians. Dmand AI also links Limitha Adimala to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Limitha Adimala practices. Vendor and product names are available with a free account.

Internal medicine is Limitha Adimala's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Limitha Adimala is licensed in Alabama.

CMS data shows 74 Medicare services from Limitha Adimala across 2 procedure codes in 2024, for 31 Medicare patients. Medicare paid $6,535 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Limitha Adimala in 2024. The largest group is under 65, with 14 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 55% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Limitha Adimala's median patient age at 63, with 48% women.

In 2024, Limitha Adimala wrote 148 Medicare Part D claims for 39 patients. 86% of them were for generic drugs. They cover 12 drugs, with $3,261 in total drug cost. In 2022, CMS named 48 claims across 4 drugs.

Limitha Adimala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 39 general payments to Limitha Adimala from 12 drug and device companies from 2017 to 2021. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $179.